2016
DOI: 10.1136/gutjnl-2016-312388.72
|View full text |Cite
|
Sign up to set email alerts
|

OC-073 The First Multicentre Experience from The UK and Ireland of the Use of the Hot Axios System for Transluminal Drainage of Pancreatic Fluid Collections

Abstract: IntroductionPancreatic fluid collections (PFC) are a common local complication of pancreatitis with incidences of 5–16% and 20–40% in acute and chronic pancreatitis, respectively.1 Classification of PFC includes acute peripancreatic fluid collection, pancreatic pseudocyst, acute necrotic collection and walled-off necrosis (WON). A new lumen-apposing, covered self-expanding metal stent on a catheter-based delivery system (Hot AXIOS, Boston Scientific) may have higher technical success rates, easier deployment a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 0 publications
0
5
2
Order By: Relevance
“…A recent study, using the previous generation LAMS (AXIOS; Boston Scientific), showed superiority of LAMS over plastic stents but with more adverse events 8 . In contrast, in our study of the second-generation device, the adverse event rate (utilizing the same definitions of bleeding, perforation, and misplacement) was low (3 %), and other studies of the device have also reported very low procedural adverse events 9 10 . A possible explanation is that placement of the first-generation device requires the same multiple steps and therefore potential for adverse events as other metal and plastic stents.…”
Section: Discussioncontrasting
confidence: 80%
See 2 more Smart Citations
“…A recent study, using the previous generation LAMS (AXIOS; Boston Scientific), showed superiority of LAMS over plastic stents but with more adverse events 8 . In contrast, in our study of the second-generation device, the adverse event rate (utilizing the same definitions of bleeding, perforation, and misplacement) was low (3 %), and other studies of the device have also reported very low procedural adverse events 9 10 . A possible explanation is that placement of the first-generation device requires the same multiple steps and therefore potential for adverse events as other metal and plastic stents.…”
Section: Discussioncontrasting
confidence: 80%
“…Conversely, a recent report from an ongoing randomized controlled trial of the second-generation LAMS and plastic stents for drainage of WON reported a very high rate of stent-related bleeding for LAMS (n = 3/12; 25 %) 124. However, other larger registry-based studies have not reported a similar problem 9 10 25 , and neither did our series, with fewer immediate adverse events. The results of the completed study are awaited.…”
Section: Discussioncontrasting
confidence: 77%
See 1 more Smart Citation
“…Small retrospective studies have demonstrated that the AXIOS stent has a higher technical success rate (98.9%) when compared to fully covered self-expanding metal stents and double pigtail stents. [ 2 10 11 12 ] These studies also concluded that the AXIOS stent achieves a PFC clinical resolution rate in 92.5% of cases. [ 2 10 11 12 ] The reported complication rate in these studies ranged from 5% to 9.4%.…”
Section: Discussionmentioning
confidence: 94%
“…Endoscopic necrosectomy is not a procedure in isolation, but part of the repertoire of a specialist pancreatic unit, and specialist multi disciplinary team (MDT) discussion is critical. A new generation of single device lumen apposing metal stents has recently become available; the UK experience of its use for drainage of pancreatic fluid collections21 has recently been presented. We have also demonstrated that it can be used for EUS-guided drainage of the gall bladder 22…”
Section: Innovation In Therapeutic Eusmentioning
confidence: 99%